NeuroBo Pharmaceuticals, Inc. (NRBO)

NASDAQ: NRBO · IEX Real-Time Price · USD
0.455
-0.004 (-0.76%)
At close: Jun 24, 2022 4:00 PM
0.498
+0.044 (9.571%)
Pre-market: Jun 27, 2022 7:29 AM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020201920182017201620152014
Selling, General & Admin
8.757.852.71.6110.445.963.180.21
Research & Development
6.554.535.325.0722.698.743.990.05
Other Operating Expenses
017.3412.158.820.0100.910
Operating Expenses
15.329.7220.1815.4933.1314.78.080.27
Operating Income
-15.3-29.72-20.18-15.49-33.13-14.7-8.08-0.27
Interest Expense / Income
000.020.040.29-0.110.760.06
Other Expense / Income
-0.01-0.041.110000.19-0
Pretax Income
-15.28-29.68-21.31-15.53-33.42-14.59-9.03-0.32
Net Income
-15.28-29.68-21.31-15.53-33.42-14.59-9.03-0.32
Preferred Dividends
000000.374.020
Net Income Common
-15.28-29.68-21.31-15.53-33.42-14.95-13.04-0.32
Shares Outstanding (Basic)
2316540000
Shares Outstanding (Diluted)
2316540000
Shares Change
42.71%210.43%22.88%926.98%78.14%102.06%88.94%-
EPS (Basic)
-0.66-1.83-4.08-3.65-80.75-64.25-113.50-5.25
EPS (Diluted)
-0.66-1.83-4.08-3.65-80.75-64.25-113.50-5.25
Free Cash Flow Per Share
-0.65-0.66-1.39-3.40-64.98-47.52-47.24-3.20
EBITDA
-15.21-29.61-21.27-15.49-33.13-14.7-8.27-0.27
Depreciation & Amortization
0.070.070.0200000
EBIT
-15.28-29.68-21.29-15.49-33.13-14.7-8.27-0.27
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).